Shaw and Partners Chief Investment Officer Martin Crabbe outlines a four-part investment strategy, focusing on growth, financial conditions, central bank policy and valuation. He notes that valuations remain high. He advises investors to adopt an active strategy, selecting individual growth-oriented stocks instead of relying on index funds.
Copyright 2024 – Finance News Network
Source: Finance News Network
20 Aug 2025 - Sovereign Advisors Principal Advisor Zaheer Lalani and Investment Manager Max Riaz provide a quarterly update on the markets.
Read More21 May 2021 - Hazer Group Limited (ASX:HZR) CEO & Managing Director Geoff Ward provides an update on the company's Commercial Development Project at the Woodman Point Wastewater Treatment Plant south of Perth, a 100 tonne per annum hydrogen production facility using waste gas produced through the water treatment facilities.
Read More04 Jul 2022 - Magnetite Mines Limited (ASX:MGT) new board member Simon Wandke discusses his background, what he will bring to the company and the company's outlook.
Read More28 Aug 2019 - Ingenia Communities Group Limited (ASX:INA) CFO, Scott Noble discusses the company's FY19 results, its portfolio and the demand for seniors' accommodation.
Read More01 Jun 2020 - NetLinkz Limited (ASX:NET) Executive Chairman & CEO James Tsiolis provides an update on the company's suite of networking solutions, the market opportunity and progress with partners.
Read More21 Mar 2021 - Elixinol Global (ASX:EXL) CEO, Oliver Horn talks about its proposed acquisition of CannaCare Health GmbH (CannaCare) one of Germany’s leading CBD (Cannabidiol) brands following the down scheduling of CBD in Europe late last year in what the Company sees as highly strategic opportunity and important pathway to profitability.
Read More27 Oct 2022 - icetana Limited (ASX:ICE) CEO and Managing Director Matt Macfarlane discusses the company's recent deal with Japanese group Macnica and the launch of a new product.
Read More26 Aug 2021 - Chimeric Therapeutics Limited (ASX:CHM) Chief Operating Officer Jennifer Chow talks about the company's licensing of a novel, third-generation CDH17 CAR T cell therapy from the University of Pennsylvania, its recent FDA IND clearance and plans for ongoing growth.
Read More26 Sep 2019 - First Graphene Limited (ASX:FGR) Executive Director and CFO, Peter Young talks about the company's worldwide licensing agreement with the University of Manchester for its technology used in supercapacitors.
Read More30 Jul 2021 - Novatti Group Limited (ASX:NOV) CEO, Peter Cook, provides an update on activities from the company's June quarter, discussing growth in platforms and infrastructure and the recent capital raise.
Read More
